Structural Aspects of Receptor Dimerization

[1]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[2]  al. et,et al.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.

[3]  M. Eisenstein,et al.  The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction , 1995, Cell.

[4]  M. Brizzi,et al.  Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. , 1994, The Journal of biological chemistry.

[5]  M. Jaye,et al.  Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation , 1994, Cell.

[6]  E. Peles,et al.  ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. , 1994, The Journal of biological chemistry.

[7]  M. Erdos,et al.  Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling , 1994, Nature.

[8]  M. Vadas,et al.  A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity. , 1994, Blood.

[9]  A. Ullrich,et al.  Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. , 1994, The Journal of biological chemistry.

[10]  M. Preece,et al.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization. , 1994, The EMBO journal.

[11]  H. Serve,et al.  Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. , 1994, The Journal of biological chemistry.

[12]  P. Cosson,et al.  Role of transmembrane domains in assembly and intracellular transport of the CD8 molecule. , 1993, The Journal of biological chemistry.

[13]  L. Wang,et al.  Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros , 1993, Journal of virology.

[14]  G. Rodrigues,et al.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase , 1993, Molecular and cellular biology.

[15]  I. Lax,et al.  Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. , 1993, Biochemistry.

[16]  C. Kahn,et al.  Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Schmid,et al.  Dimerization of extracellular domains of platelet-derived growth factor receptors. A revised model of receptor-ligand interaction. , 1993, The Journal of biological chemistry.

[18]  J. Xu,et al.  Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants , 1993, Molecular and cellular biology.

[19]  B. Yang,et al.  Role of oligosaccharides in the processing and function of human transferrin receptors. Effect of the loss of the three N-glycosyl oligosaccharides individually or together. , 1993, The Journal of biological chemistry.

[20]  S. Nishikawa,et al.  Interspecies molecular chimeras of kit help define the binding site of the stem cell factor , 1993, Molecular and cellular biology.

[21]  M. Brizzi,et al.  Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. , 1993, The Journal of biological chemistry.

[22]  M. Barbacid,et al.  Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.

[23]  S. Lev,et al.  Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor. , 1992, The Journal of biological chemistry.

[24]  Y. Rao,et al.  Identification of a peptide sequence involved in homophilic binding in the neural cell adhesion molecule NCAM , 1992, The Journal of cell biology.

[25]  S. Lev,et al.  A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. , 1992, Journal of Biological Chemistry.

[26]  H. Lodish,et al.  Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  V. Duronio,et al.  p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Bormann,et al.  A subdomain in the transmembrane domain is necessary for p185neu* activation. , 1992, The EMBO journal.

[29]  S. Aaronson,et al.  A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. , 1992, The Journal of biological chemistry.

[30]  M. Roussel,et al.  Random mutagenesis of CSF‐1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. , 1992, The EMBO journal.

[31]  D. Williams,et al.  c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. , 1992, Molecular biology of the cell.

[32]  S. Lev,et al.  Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Mulvey,et al.  Three dimensional structure of the transmembrane region of the proto‐oncogenic and oncogenic forms of the neu protein. , 1992, The EMBO journal.

[34]  P. Besmer.  The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. , 1991, Current opinion in cell biology.

[35]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[36]  A. Ullrich,et al.  Substrate phosphorylation specificity of the human c-kit receptor tyrosine kinase. , 1991, The Journal of biological chemistry.

[37]  S. Nagata,et al.  Functional domains of the granulocyte colony‐stimulating factor receptor. , 1991, The EMBO journal.

[38]  Alastair,et al.  Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. , 1991, The EMBO journal.

[39]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[40]  W. Rutter,et al.  Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Stanley,et al.  Role of dimerization and modification of the CSF‐1 receptor in its activation and internalization during the CSF‐1 response. , 1991, The EMBO journal.

[42]  A. Ullrich,et al.  A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation. , 1991, The Journal of biological chemistry.

[43]  H. Lodish,et al.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.

[44]  W. Rutter,et al.  The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.

[45]  Y. Yarden,et al.  Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Wang,et al.  Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. , 1989, The Journal of biological chemistry.

[47]  J. Khire,et al.  Ligand-induced dimerization of the platelet-derived growth factor receptor. Monomer-dimer interconversion occurs independent of receptor phosphorylation. , 1989, The Journal of biological chemistry.

[48]  D. Weiner,et al.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation , 1989, Nature.

[49]  R. Dwek,et al.  A comparative analysis of disease-associated changes in the galactosylation of serum IgG. , 1989, Journal of autoimmunity.

[50]  L. Rohrschneider,et al.  Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phenotype , 1988, Cell.

[51]  J. Schlessinger,et al.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.

[52]  P. Pilch,et al.  Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[54]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[55]  S. Lev,et al.  Steel factor and c-kit protooncogene: genetic lessons in signal transduction. , 1994, Critical reviews in oncogenesis.

[56]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[57]  J. Downing,et al.  Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains. , 1990, Oncogene.

[58]  G. Alcaraz,et al.  The receptor with high affinity for immunoglobulin E. , 1986, Annual review of immunology.